These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6135967)

  • 1. The effect of the beta-adrenoreceptor antagonist Ro03-7894 on rat atrial tension development and (-)-[3H]dihydroalprenolol binding to cardiac and lung membranes.
    Baker SP; Posner P
    Life Sci; 1983 Aug; 33(5):459-66. PubMed ID: 6135967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the apparent irreversible beta-adrenoceptor antagonist Ro 03-7894 with propranolol in cardiac ventricular muscle by pharmacological and radioligand binding techniques.
    Rankin A; Broadley KJ
    Biochem Pharmacol; 1982 Apr; 31(7):1325-32. PubMed ID: 6124256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo.
    Baker SP; Pitha J
    J Pharmacol Exp Ther; 1982 Feb; 220(2):247-51. PubMed ID: 6120224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential recovery of beta adrenoreceptor antagonist and agonist high affinity binding sites in the guinea-pig lung after irreversible blockade.
    Nelson CA; Muther TF; Pitha J; Baker SP
    J Pharmacol Exp Ther; 1986 Jun; 237(3):830-6. PubMed ID: 2872326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of bromoacetylalprenololmentane on rat atrial tension development and beta-adrenoreceptors.
    Posner P; Peterson CV; Pitha J; Baker SP
    Eur J Pharmacol; 1984 May; 100(3-4):373-6. PubMed ID: 6329781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding.
    Chang RS; Lotti VJ
    Life Sci; 1983 May; 32(22):2603-9. PubMed ID: 6134224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for two specific affinity states of 3H-antagonist binding to cardiac beta-adrenergic receptors and influence of Gpp(NH)p.
    Lang PH; Lemmer B
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):341-60. PubMed ID: 2993385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of lipolytic activities in the genetically obese Zucker fatty rats--experimental study on (-)-[3H]dihydroalprenolol binding in the intact fat cells].
    Matsumoto G
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1145-59. PubMed ID: 6141076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ-bath studies using the irreversible beta-adrenoreceptor antagonist bromoacetylalprenololmenthane (BAAM).
    Ng NL; Malta E
    J Auton Pharmacol; 1989 Jun; 9(3):189-200. PubMed ID: 2568361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding characteristics of 3H-dihydroalprenolol to beta-adrenoceptors of rat heart treated with neuraminidase.
    Nagatomo T; Sasaki M; Tsuchihashi H; Imai S
    Jpn J Pharmacol; 1983 Aug; 33(4):851-7. PubMed ID: 6314011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites.
    Landi M; Bianchetti A; Croci T; Manara L
    Biochem Pharmacol; 1992 Aug; 44(4):665-72. PubMed ID: 1354964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two beta-adrenergic pharmacophores on the same molecule. A set of agonist-antagonist combinations.
    Kusiak JW; Heja G; Pitha J
    Biochem Pharmacol; 1987 Jan; 36(2):269-75. PubMed ID: 2880591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromoacetylalprenololmenthane: a potent irreversible antagonist of beta adrenergic elicited protein exocytosis in rat parotid cells.
    Kousvelari EE; Kusiak JW; Hand AR; Pitha J; Baum BJ
    J Pharmacol Exp Ther; 1983 Oct; 227(1):238-43. PubMed ID: 6194285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of L-[propyl-2,3-3H]dihydroalprenolol by intact HeLa cells.
    Meier KE; Ruoho AE
    Biochim Biophys Acta; 1984 Jul; 804(3):331-40. PubMed ID: 6146352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences of isoproterenol pretreatment on cerebral cortical bindings of [3H]clonidine and [3H]dihydroalprenolol in infant and adult rats.
    Nomura Y; Yotsumoto I; Motomori-Suzaki E; Kawai M; Segawa T
    Brain Res; 1983 Sep; 285(3):381-4. PubMed ID: 6627028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the binding characteristics of the beta-adrenoceptor antagonists 3H-dihydroalprenolol and 125I-iodocyanopindolol in rat liver.
    Sandnes D; Westergren T; Sand TE; Sager G; Refsnes M; Christoffersen T; Jacobsen S
    Acta Pharmacol Toxicol (Copenh); 1984 Oct; 55(4):287-96. PubMed ID: 6150600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodological aspects of receptor research: problems in the assessment of specific and non-specific binding of 3H-dihydroalprenolol to bovine lung membranes.
    Richardson A; Nahorski SR
    Eur J Respir Dis Suppl; 1984; 135():114-23. PubMed ID: 6329797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of (-)-[3H]dihydroalprenolol binding to intact and broken cell preparations of human peripheral blood lymphocytes.
    Meurs H; van den Bogaard W; Kauffman HF; Bruynzeel PL
    Eur J Pharmacol; 1982 Nov; 85(2):185-94. PubMed ID: 6295780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic receptors in guinea-pig liver plasma membranes and thermal lability of [3H]dihydroalprenolol binding sites.
    Kawai Y; Graham SM; Yoshioka H; Arinze IJ
    Biochem Pharmacol; 1986 Dec; 35(24):4387-93. PubMed ID: 3024648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.